Medical Device News Magazine

Cardiothoracic Surgeon to Lead Smidt Heart Institute’s ECMO Program

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The Smidt Heart Institute at Cedars-Sinai has selected board-certified cardiothoracic surgeon Tyler Gunn, MD, to be the director of the Extracorporeal Membrane Oxygenation, or ECMO, Program in the Department of Cardiac Surgery.

Gunn, who was both a resident and fellow during the COVID-19 pandemic, says his time spent on the medical front lines fueled his passion for treating patients on ECMO.

When ECMO is used, blood is pumped outside of the body to a portable heart-lung machine. The machine removes carbon dioxide from the blood, then sends oxygen-rich blood back into the body. In the past, this process was often considered a Hail Mary pass appropriate only for patients for whom all other therapies failed. During the global pandemic, however, ECMO proved increasingly successful in saving-and extending-lives.

“In my last year of surgical residency, I worked in a hospital where most of the patients we treated were unvaccinated against COVID-19 and many of them required ECMO for survival,” said Gunn. “I learned alongside my mentor, who happened to be a co-inventor of ECMO, which further fueled my understanding and interest in its use.”

An Iowa native, Gunn earned his bachelor’s degree in chemical engineering and his medical degree from the University of Iowa. He completed his surgical residency at the University of Kentucky.

Gunn then spent his fellowship year at the Smidt Heart Institute, training alongside some of the most respected experts in cardiothoracic transplant surgery and ECMO. It was during this time that Smidt Heart Institute experts reported that in carefully selected COVID-19 patients, ECMO could be a successful therapy as a bridge to lung transplantation, or to allow a patient’s own lungs to heal.

Joanna Chikwe, MD, founding chair of the Department of Cardiac Surgery in the Smidt Heart Institute at Cedars-Sinai, the Irina and George Schaeffer Distinguished Chair in Cardiac Surgery, served as corresponding author of the novel clinical data that supported wider use of ECMO. The data was published via an analysis in The New England Journal of Medicine.

The analysis included more than 3,000 lung transplantations that took place in the U.S. between Aug. 1, 2020, and Sept. 30, 2021. Smidt Heart Institute researchers showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed either ventilators or ECMO before their transplant.

“The ways in which we utilize ECMO today are vastly different than two years ago,” said Chikwe. “We have a real opportunity to continue pushing the boundaries and to solidify new ways we utilize-and study-ECMO in the academic medical center setting.”

Chikwe says these new opportunities are best for Gunn, whose excellence and eagerness will continue to propel the paradigm shift in the use of ECMO.

“Not only can we count on him to save lives as a surgeon,” Chikwe said, “but we know he will build upon and advance our ECMO program, ultimately benefiting the many patients who rely on this lifesaving intervention.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.